Ledger.Open graph →

SEC Form D · filed December 16, 2020

Tetherex Pharmaceuticals Corp

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

OKLAHOMA CITY, OK

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Jonathan Stocker, Ph.D · Cary, NCExec Rodger Mcever, M.D · OKLAHOMA CITY, OKDirector Scott Rollins, Ph.D · OKLAHOMA CITY, OKExec · Director Russell Rother, Ph.D · OKLAHOMA CITY, OKExec · Director Richard Alvarez · Edmond, OKExec Todd Foley · Boston, MADirector Philip Jones, M.D · Norman, OKDirector David Keiser · Madison, CTDirector Paul R. Mccullough · Minneapolis, MNExec Matthew S. Fisk · Minneapolis, MNExec · Director Jurg Schappi · Dublin, IrelandExec Philip Jones, M.D · Norman, OKDirector Scott Samara · Oklahoma City, OKDirector Nicolas Motelay · Dublin, IrelandDirector Randy Maksymowich · Calgary, Alberta, CanadaExec · Director Mark Poelzer · Calgary, Alberta, CanadaExec · Director James Davis · Calgary, Alberta, CanadaDirector Paul M. Britton · New York, NYExec · Director Arthur Rosen · New York, NYDirector Chandler Jones · Saco, MEExec · Director Richard L. Baum · Huntington, NYExec Scott Samara · Oklahoma City, OKDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗